Aridis制药(ARDS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARDS Aridis制药

休市中 08-15 16:00:00 EDT 延时

{"stockData":{"symbol":"ARDS","market":"US","secType":"STK","nameCN":"Aridis制药","latestPrice":0.0001,"timestamp":1755288000000,"preClose":0.0001,"halted":0,"volume":0,"delay":15,"floatShares":37958700,"shares":44574000,"eps":-0.039914,"marketStatus":"休市中","change":0,"latestTime":"08-15 16:00:00 EDT 延时","open":0.0001,"high":0.0001,"low":0.0001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.039914,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1755504000000},"marketStatusCode":7,"adr":0,"exchange":"EXPERT","adjPreClose":0.0001,"volumeRatio":0.08242182058506137},"requestUrl":"/m/hq/s/ARDS","defaultTab":"news","newsList":[{"id":"2539022182","title":"一批大牛股，最新披露！","url":"https://stock-news.laohu8.com/highlight/detail?id=2539022182","media":"数据宝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539022182?lang=zh_cn&edition=full","pubTime":"2025-05-31 12:11","pubTimestamp":1748664660,"startTime":"0","endTime":"0","summary":"近一周机构调研个股数量有530多只，拓荆科技调研机构数最多。　　公司在调研中称，2025年第一季度营业收入同比增长50.22%，主要由于国内下游客户半导体设备需求增加，公司新产品在客户端实现批量验证，收入保持高增长态势。　　此外，还有金帝股份、华丰科技、科兴制药、聚辰股份等个股近一周机构数量较多；其中科兴制药、艾力斯等个股属于近期火爆的创新药板块。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/2025-05-31/doc-ineymseh0108574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","ARDS","06978","BK4139","BK1161"],"gpt_icon":0},{"id":"2539251567","title":"300204，8天翻倍！600358，重大资产重组，近百万手封死涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2539251567","media":"数据宝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539251567?lang=zh_cn&edition=full","pubTime":"2025-05-29 12:42","pubTimestamp":1748493720,"startTime":"0","endTime":"0","summary":"截至上午收盘，该股依然有近100万手封死涨停。收购方个股在2024年9月24日至2025年5月22日期间，有57%实现超额收益，显著高于出让方的40%。300204，8天翻倍除了重组题材，近期创新药表现持续向好。早盘，舒泰神再度“20cm”涨停，短短8个交易日股价翻倍。2025年ASCO年会上，中国药企以70余项研究成果入选，国产创新药再次闪耀世界舞台。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA4MDU0MzQ4Mg==&mid=2653393362&idx=1&sn=bd45d503d527416f2db9af7b447c3d17&chksm=85b98f464612641bed517926b9df8e159b767aa2d19ee7384b60e0dcfbf81071254c41699813&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["ARDS","BK4139"],"gpt_icon":0},{"id":"2539286146","title":"【创新药概念再度走强 舒泰神涨超15%创3年新高】早盘舒泰神涨超15%，股价创3年多新高，键凯科技、博瑞医药、健友股份、三生国健、益方生物等涨幅靠前。消息面上，舒泰神公告，STSA-1002注射液在急性呼吸窘迫综合征（ARDS）适应症下获得了Ib/II期临床试验研究的初步结果。28天全因死亡率数据显示，低剂量组和高剂量组分别为26.67%和5.88%，较对照组的40%分别降低了33.33%和85.3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539286146","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539286146?lang=zh_cn&edition=full","pubTime":"2025-05-29 09:42","pubTimestamp":1748482932,"startTime":"0","endTime":"0","summary":"早盘舒泰神涨超15%，股价创3年多新高，键凯科技、博瑞医药、健友股份、三生国健、益方生物等涨幅靠前。消息面上，舒泰神公告，STSA-1002注射液在急性呼吸窘迫综合征（ARDS）适应症下获得了Ib/II期临床试验研究的初步结果。28天全因死亡率数据显示，低剂量组和高剂量组分别为26.67%和5.88%，较对照组的40%分别降低了33.33%和85.3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/29094250733134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03347","BK1161","BK1583","BK0229","ARDS","BK4139","603707","STSA","BK0186","BK0028","BK0239","688166","159992","688382","688356","06978","BK1141","BK1574","BK0046","300204","BK4007","688336","BK1576"],"gpt_icon":0},{"id":"2482460615","title":"高价收技术，持续巨亏！探秘天价股权激励背后的故事","url":"https://stock-news.laohu8.com/highlight/detail?id=2482460615","media":"星空财研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482460615?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:25","pubTimestamp":1730971523,"startTime":"0","endTime":"0","summary":"大家都知道，国内在生物医药领域和头部国家们还有较大的差距，不过近些年来在不少细分领域，国内企业奋起直追，在极个别领域中取得了先发优势。来自北京的泽辉生物科技有限公司（简称：泽辉生物）就是一家拥有一定....","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241107A078B300","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241107A078B300","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1161","02257","02197","ARDS","BK4139","PSC"],"gpt_icon":0},{"id":"2474741579","title":"美国OTC市场Aridis Pharmaceuticals Inc.盘中异动 股价大涨9900.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474741579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474741579?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:49","pubTimestamp":1728568141,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时49分，美国OTC市场Aridis Pharmaceuticals Inc.股票出现异动，股价大幅上涨9900.00%。截至发稿，该股报0.000美元/股，成交量5125股，换手率0.01%，振幅0.00%。美国OTC市场Aridis Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.33%。美国OTC市场Aridis Pharmaceuticals Inc.公司简介：Aridis Pharmaceuticals Inc是一家后期生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010214901959da9af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010214901959da9af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARDS"],"gpt_icon":0},{"id":"2468572671","title":"Mesoblast Ltd盘中异动 快速拉升5.01%报6.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468572671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468572671?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:30","pubTimestamp":1726752647,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时30分，Mesoblast Ltd股票出现波动，股价快速拉升5.01%。截至发稿，该股报6.50美元/股，成交量1.3716万股，换手率0.01%，振幅0.00%。Mesoblast Ltd股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Exicure, Inc.、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1004.66%、315.64%、66.92%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Protalix Biotherapeutics, Inc. ，振幅分别为14.45%、5.51%、5.50%。Mesoblast Ltd公司简介：Mesoblast Ltd 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091921304798e38149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091921304798e38149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MESO","BK4139","ARDS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aridispharma.com","description":"Aridis Pharmaceuticals, Inc.于2003年成立为加利福尼亚州有限责任公司。公司于2014年5月21日转为特拉华C公司，是一家后期生物制药公司，专注于发现和开发靶向免疫疗法。人单克隆抗体或单克隆抗体，用于治疗威胁生命的感染。单克隆抗体代表传染病市场中一种全新的治疗方法，旨在克服与当前治疗相关的关键问题，包括耐药性，反应持续时间短，对人类微生物组的负面影响，以及治疗方案之间缺乏区别。Aridis Pharmaceuticals的专利产品系列包括针对与威胁生命的细菌感染相关的特定病原体的完全人类单克隆抗体，主要是院內肺炎，或HAP，以及呼吸机相关性肺炎或VAP。","exchange":"EXPERT","name":"Aridis制药","nameEN":"Aridis Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.8","shortVersion":"4.34.8","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aridis制药(ARDS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aridis制药(ARDS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aridis制药,ARDS,Aridis制药股票,Aridis制药股票老虎,Aridis制药股票老虎国际,Aridis制药行情,Aridis制药股票行情,Aridis制药股价,Aridis制药股市,Aridis制药股票价格,Aridis制药股票交易,Aridis制药股票购买,Aridis制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aridis制药(ARDS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aridis制药(ARDS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}